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Background: High costs still limits the widespread use of xenon in the clinical practice. Therefore, we evaluated
xenon consumption of different delivery modes during general surgery.
Methods: A total of 48 patients that underwent general surgery with balanced xenon anaesthesia were
retrospectively analysed according to the mode of xenon delivery during maintenance phase (ECO mode, AUTO
mode or MANUAL mode).
Results: Xenon consumption was highest during the wash-in phase (9.4 ± 2.1l) and further decreased throughout
maintenance of anaesthesia. Comparison of different xenon delivery modes revealed significant reduced xenon
consumption during ECO mode (18.5 ± 3.7L (ECO) vs. 24.7 ± 11.5L (AUTO) vs. 29.6 ± 14.3L (MANUAL); p = 0.033). No
differences could be detected with regard to anaesthetic depth, oxygenation or performance of anaesthesia.
Conclusion: The closed-circuit respirator Felix Dual offers effective reduction of xenon consumption during general
surgery when ECO mode is used.
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Official permission for xenon to be used as an anaes-
thetic was issued by the German Medical Products and
Drugs authorities in October 2005 and by the European
Medicines Evaluation Agency in March 2007. Since that
time a growing body of evidence indicates xenon`s bene-
ficial cardio- and neuroprotective characteristics [1-8].
In addition, xenon offers various characteristics of an
ideal anaesthetic gas with a favourable safety profile
[9, 10]. In particular its fast recovery after termination of
anaesthesia underlines its desirable pharmacodynamics
in the clinical practice [11].
Despite these promising findings, the high costs of
xenon (about more or less 20€/L) and increased xenon
consumption, resulting from high gas concentration
needed to achieve target concentration, limit the general
use of this auspicious anaesthetic during general anaes-
thesia [12, 13]. Therefore the challenge of high cost and* Correspondence: mcoburn@ukaachen.de
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reproduction in any medium, provided the orthe favourable properties form an obstacle that necessar-
ily has to be overcome. The combination of recent tech-
nologic developments of closed-circuit respirators, the
small blood-gas partition coefficient and the low patient
uptake in average adults offers promising approaches to
reduce gas consumption and the resulting costs [13, 14].
Although the highest xenon consumption is known to
occur during the first hour of anaesthesia, effective strat-
egies to counteract this discrepancy are still lacking [15].
The closed-circuit respirator Felix Dual (Felix Dual™, Air
Liquide Medical Systems, France) offers encouraging
possibilities for an overall effective reduction of gas
consumption.
The aim of the present study was to evaluate the po-
tential xenon sparing effects of Felix Dual™ that might
be provided by the available xenon delivery mode ECO,
AUTO and MANUAL.
Therefore we investigated gas consumption of xenon
throughout different periods of anaesthesia and further
investigate different modes of delivery. We hypothesize
that xenon consumption might be effectively reduced
using ECO mode from Felix Dual respirator.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Stoppe et al. Medical Gas Research 2013, 3:12 Page 2 of 11
http://www.medicalgasresearch.com/content/3/1/12Methods
Patients and study design
The present study was part of a large prospective, ran-
domized clinical trial carried out at the University
Hospital of the RWTH Aachen between 2008 and 2011.
After obtainment of written informed consent, patients
enrolled in the trial were initially randomly assigned to
one of the two study arms (xenon vs. sevoflurane) and
blinded to receiving either sevoflurane or xenon. Data
on xenon consumption and administration were recor-
ded automatically in 50 patients. We retrospectively
analysed the recorded data from those patients who
were consecutively enrolled and randomized to receive
xenon anaesthesia.
The study was registered at the EMA (EudraCT
number: 2008-004132-20) and at ClinicalTrials.gov
(NCT number: 00793663). The local institutional ethics
committee and the German federal drug administration
(BfArM) approved the study. Ethical approval for this
study (EK 110/08) was provided by the Ethical Committee
of RWTH Aachen University, Aachen, Germany (Chair-
person Prof. G. Schmalzing) on 18. September 2008.
All screened patients were eligible, if they were classi-
fied for ASA I-II physical status category and who were
undergoing gynaecologic or urologic abdominal surgery.
Baseline characteristics (age, sex, height, weight and cal-
culated BMI) were documented separately.
Exclusion criteria were severe cardiac dysfunction (e.g.
recent myocardial infarction, heart failure, acute coron-
ary syndrome within the last 24 hours prior to surgery),
asthma, acute or chronic obstructive pulmonary dys-
function (COPD), acute or chronic liver or renal failure
(creatinine > 1.5 mg/dl), history of hypersensitivity, sus-
picion of malignant hyperthermia and known or sup-
posed pregnancy.
Respirator
Felix Dual is a xenon-capable ventilator. It offers all
state-of-art ventilation modes for anaesthesia (volume
controlled, pressure controlled and pressure support
modes), safe operation at minimal fresh gas flow (0,5 l/
min), an integrated sidestream gas monitoring systems
for measurements of inspiratory and expiratory gases an-
aesthetics. Although the circuit was initially controlled
at not lower than 0,5 L/min, it is capable to ventilate in
closed-circuit and drive intermittently the electronic
mixer at very low and precise flow. Furthermore the
ventilator allows a flexible inspiratory and expiratory
flow measurement and determination of the xenon con-
centration in the breathing gas.
Felix Dual is designed with two automated xenon ad-
ministration modes, the ECO and AUTO mode, which
are specifically designed to allow conducting of xenon
anaesthesia under affordable and safe conditions.Induction and maintenance anaesthesia
After admission to the operation theatre standard moni-
toring of cardiovascular and respiratory function was
established (ECG, peripheral Saturation SPO2, non-
invasive blood pressure (DatexOhmeda AS/3 monitor,
GE Healthcare, Helsinki, Finland).
All patients received standardized anaesthesia accor-
ding to our study protocol. Induction of anaesthesia was
performed using propofol (2.0 mg · kg-1) and remifen-
tanyl infusion (0.5 μg kg-1 · min-1) over a period of 60
seconds, followed by a reduction to 0.15 μg · kg-1 · min-1
if appropriate. Muscle relaxation was obtained with
rocuronium bromide (0.6 mg · kg-1 bolus for intubation,
0.1 to 0.15 mg · kg-1 repetitive boli as needed for anaes-
thesia and surgery). After tracheal intubation the main-
tenance of general anaesthesia followed by remifentanil
(0.15 μg · kg-1 · min-1) and (target concentration of 53–62
vol% expiratory xenon). Intraoperative treatment was
standardized according to our clinical routine and
recorded subsequently (anaesthesia time, opiate, propo-
fol, rocuronium bromideand gas consumption) [16].
Adjustment of anaesthetic depth was performed by
adapting end-expiratory xenon concentration depending
on significant physiological changes (e.g. difference
(>20%) of the baseline arterial pressure or heart rate, in-
crease of inspiratory pressure or expiratory CO2 or
major change of end-tidal anaesthetic-agent concentra-
tion, intermittent spontaneous breathing and/or intoler-
ance of mechanical ventilation, coughing, abdominal
pressing, sweating and eye tearing). Additionally bispec-
tral index (BIS VISTA™ monitor, software 2.00, Aspect
Medical Systems – Covidien // BIS Model A 2000®, Soft-
ware Version 2.21, Aspect Medical Systems, Boston,
MA, USA) was used for the assessment of adequate an-
aesthetic depth (recommended reference range for gen-
eral anaesthesia ranged from 40 to 60.). The monitoring
was maintained from arriving in the operation theatre
until full recovery after stop of anaesthesia.
At the end of surgery (after spontaneous recovery of
neuromuscular block), patients were allowed to breathe
100% oxygen and transferred to the Post Anaesthesia
Care Unit after tracheal extubation. Two and 12 hours
postoperatively the occurrence of intraoperative aware-
ness was assessed by an independent physician using the
Brice questionnaire [17].
Xenon administration and ventilation modes
The Felix Dual respirator (version mid-2007) allows
measuring the xenon concentration by a hot wire sensor
in series with the conventional side stream gas monitor-
ing and is compatible with xenon or other inhalation an-
aesthetics administration.
When applying xenon anaesthesia, the first phase was
similar to any other general anaesthesia with a classical
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an intravenous agent. After loss of consciousness and
intubation of the trachea the denitrogenation started
(ventilating with 100% O2 with 6 to 12 L/min). The pur-
pose of the denitrogenation was to support exhalation of
nitrogen. Denitrogenation was considered as terminated
when the expiratory O2 concentration reaches 91%-92%.
At that time, the Felix Dual could be switched to either
automated ECO or AUTO mode. In the ECO mode,
during wash-in phase, xenon flow was initially set to 0.5
L/min. While the inspiratory O2 concentration progres-
sively decreased the expiratory xenon concentration sim-
ultaneously increased until target concentrations were
reached. During maintenance phase, xenon injections
were automatically performed to maintain regular venti-
lation with expiratory xenon concentration not lower
than 11% below target xenon concentration. In this
mode, we expected xenon injections to occur periodic-
ally each 10 to 20 minutes depending on O2 and Xenon
patient uptake or when expiratory concentrations have
significantly decreased (Figure 1).
In the AUTO mode, during wash-in phase, the respir-
ator aimed to reach quickly the target concentration.
The xenon injection was automatically set at a much
higher flow (about 2 L/min) resulting in excess xenon
consumption. At the end of wash-in phase, the respir-
ator automatically closed the circuit and started toFigure 1 Schematic illustration for comparison of the automated ECO
standardized ECO and AUTO mode during wash-in and maintenance, show
and the overall xenon usage. AUTO mode initially injects xenon at high flo
while the ECO mode initially injects xenon at very low flow (about 0.5 L/m
repetitively injects xenon with frequent short pulses at low flow while the
maintenance.regulate O2 and/or xenon by short-pulsed injections in
order to maintain the inspiratory O2-concentration to its
programmed target. During maintenance phase, Felix
Dual alternated short pulsed-injections of O2 and xenon
in order to compensate O2 and xenon patient uptakes
but also to continuously eliminate accumulating exhaled
strange gases. The AUTO mode aims to maintain stable
expiratory xenon concentration in the ± 5% tolerance
range (Figure 1).
In addition to the ECO and AUTO mode xenon wash-
in and maintenance were also conducted manually by
selecting the MANUAL mode. Here, setting of fresh gas
flow, O2 and xenon concentration were done individu-
ally. The MANUAL mode was as well available while
conducting the AUTO and ECO mode to wash out ac-
cumulated strange gases and compensate significant de-
creases from target concentration (e.g. in case of long
apnoea, long disconnection).
After termination of surgery the xenon application and
anaesthesia was finished by activating pure O2 flow or
O2/Air flow. Herein it was even possible to remain ei-
ther in ECO, AUTO or MANUAL mode respectively. In
case of ECO or AUTO mode during recovery, Felix Dual
was automatically set at pure O2 fresh gas flow (4 L/
min). If the recovery phase was managed in MANUAL
mode, the time needed for the patient to exhale most
part of the accumulated xenon was controlled by settingand AUTO mode. The figure illustrates the characteristics of the
ing xenon injected flow, the resulting expiratory xenon concentration
w (about 2 L/min) in order to reach fast the target concentration,
in) to be economic. Accordingly during maintenance the AUTO mode
ECO mode only injects xenon each 10 to 20 minutes during
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8 to 12 L/min).
Choice of Felix Dual Xenon administration modes for the
study
Since the Felix Dual respirator was able to deliver xenon
in different administration modes, for all of the enrolled
patients in the xenon arm, the choice of the xenon ad-
ministration mode was fully left on the discretion of
physician in charge.
For the major data analysis, all patients who received
xenon anaesthesia were retrospectively separated into 3
groups according to the delivery mode during mainten-
ance: ECO group, AUTO group and MANUAL group.
They were defined as follows:
– ECO group: All patients who received standardized
xenon delivery by the means of ECO or AUTO
mode during Wash-in and ECO mode during
maintenance phase were included in this group.
– AUTO group: All patients who received
standardized xenon delivery by the means of AUTO
or ECO mode during Wash-in and AUTO mode
during Maintenance phase were included in this
group.
– MANUAL group: All patients who received not
standardized anaesthetic delivery and/or of different
delivery modes (i.e. combination of CONTINUOUS,
ECO and/or AUTO modes) were subdivided in this
group. Therefore this group represents a not-
automated and widely inappropriate xenon
administration.
Statistical analysis
All data were statistically analysed using a commer-
cially available software package (SPSS 19.0 (SPSS inc.,
Chicago, IL, USA).
All enrolled patients that were initially randomized to
receive balanced xenon anaesthesia were retrospectively
analysed according to the xenon delivery mode during
maintenance (ECO, AUTO and MANUAL).
As primary endpoint we investigated the xenon con-
sumption using the different automated AUTO and/or
ECO mode of Felix Dual.
Secondary endpoints were the differences between
AUTO, ECO and MANUAL groups with respect to
xenon flow and gas consumption within wash-in and
maintenance. Furthermore we calculated the learning
period, which demonstrates the tendency of xenon con-
sumption over a period of 2 years. The linear trend of
the learning curve was calculated using a regression ana-
lysis and determination of correlation coefficient.
Given the explorative character of our pilot study, the
significance level of the fixed-effects results was notadjusted for multiple hypotheses (i.e., for all respiratory
variables tested in this investigation).
All data were tested for normal distribution using the
Shapiro-Wilk-W-test. Normally distributed results of
single measurements were compared using appropriate
one-way ANOVA.
Proportions were compared using the Chi-square test.




Data on gas consumption and xenon delivery were
recorded in a total of 50 patients. Follow up and final
analyses of data were performed in 48 patients. The rea-
sons for the two drops out are due to failure of continu-
ous recording of respiratory data (AUTO group) and
intraoperative switch/extend scheduled operative pro-
cedure (ECO group) (Figure 2).
Patients treated with ECO, AUTO or MANUAL mode
did not differ regarding most relevant baseline character-
istics including such as age, gender and body mass index
(Table 1). Likewise no difference could be detected
with respect to neuraxial anaesthesia, type of surgery,
remifentanil, propofol, rocuronium consumption, post-
operative analgesia and awareness (Table 2). For the dur-
ation of anaesthesia, the BIS values remained within the
recommended reference range in all patients.
Illustration of Full-ECO and Full-AUTO modes
Since the choice of delivery mode was left to the discre-
tion of the performing anaesthesiologist, the applied
delivery mode was not standardized. Patients were retro-
spectively separated into 3 groups according to their
xenon delivery mode during maintenance. To identify
the real difference between ECO and AUTO mode we
compared two small patient groups that received either
one of both delivery modes throughout wash-in and
maintenance. The total xenon consumption was signifi-
cantly reduced in the Full-ECO group in contrast to
Full-AUTO group (Table 3). Accordingly, the xenon
consumption per hour and mean end expiratory xenon
concentration were significantly reduced in the Full-
ECO group (Figure 3A-D).
In contrast to this idealized group classification (n = 8),
remaining patients (n = 40) showed different delivery-
modes during wash-in and maintenance. Therefore we
separated patients into 3 different groups according to
the applied delivery mode during maintenance.
Denitrogenation and wash-in of xenon
The mean duration of pre-oxygenation and denitrogena-
tion (time between first expiratory CO2 detection and
Figure 2 Flowchart of the study.
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no significant differences between the 3 groups.
The duration of wash-in was prolonged in the ECO
group (13.7 ± 2.8 min) and differed significantly from the
other groups (p = 0.002). In contrast the total xenon
consumption during wash-in was comparable between
ECO and AUTO group and significantly lower than in
the MANUAL group (Table 3). Considering the mean
xenon consumption throughout wash-in in all patients,
the xenon usage was high when compared to the mean
overall usage (39%), while it only represented 9% of the
mean total duration of xenon application (Table 4).Table 1 Comparison of baseline characteristics and data on s
All ECO Mode
(n = 48) (n = 11)
Demographic data:
Age (years) 46.7 ± 12.6 49.0 ± 12
Sex, male (n, %) 6 (12.5) 2 (18
Height (cm) 169.8 ± 9.3 174.1 ± 8.6
Weight (kg) 75.7 ± 17.6 76.2 ± 16
BMI (kg/m2) 26.0 ± 5.1 25.0 ± 3.4
ASA classification:
ASA I (n) 24 (50) 6 (55
ASA II (n) 24 (50) 5 (46
Data are presented as mean±SD (normally distributed data) or as absolute numbersThe high xenon consumption becomes obvious when
comparing the xenon usage in all patients during the 1st
hour (that includes induction of anaesthesia) with the fol-
lowing 2nd and 3rd hour of xenon application (1st min:
0.268 ± 0.121L/hour vs. 2nd min: 0.128 ± 0.042L/hour;
p = 0.000 and vs. 3rd hour 0.098 ± 0.056L/min; p = 0.000).
Maintenance of xenon anaesthesia
The overall duration of xenon application, xenon usage
and the corresponding xenon usage per hour are
depicted in Table 3. After completion of 1st hour, xenon
usage continuously decreased during maintenance ofurgery
AUTO Mode MANUAL Mode p-value
(n = 26) (n = 11)
.3 44.4 ± 11.6 49.6 ± 15.0 0.405
) 3 (12) 1 (9) 0.793
168.1 ± 9.6 169.6 ± 8.6 0.202
.3 71.5 ± 14.9 84.8 ± 22.2 0.109
24.9 ± 3.4 29.5 ± 8.2 0.129
) 15 (58) 3 (27) 0.225
) 11 (42) 8 (73) 0.216
(with the percentage (%) of the whole). BMI, Body Mass Index.
Table 2 Comparison of surgery related data
All ECO Mode AUTO Mode MANUAL Mode
p-value(n = 48) (n = 11) (n = 26) (n = 11)
Position:
Spine Position (n) 45 (94) 10 (91) 24 (92) 11 (100) 0.529
Lithothomy (n) 3 (6) 1 (2) 2 (4) 0 (0)
Type of peridural anaesthesia:
Lumbal (n) 3 (7) 1 (14) 2 (8) 0 (0) 0.737
Thoracal (n) 13 (32) 3 (7) 7 (17) 3 (7)
Type of surgery:
Gynaecology (n) 31 (65) 6 (55) 19 (63) 6 (55) 0.159
Urology (n) 17 (35) 6 (55) 6 (23) 5 (46)
Intraoperative data:
Anaesthesia time (min) 142 ± 44 143 ± 32.4 135.0 ± 51.0 161.2 ± 32.4 0.258
Mean remifentanyl consumption (μg/kg/min) 0.16 ± 0.07 0.14 ± 0.05 0.17 ± 0.07 0.17 ± 0.08 0.504
Propofol consumption (mg) 214.9 ± 79.4 180.0 ± 71.8 221.3 ± 64.3 235.9 ± 108 0.222
Rocuronium consumption (mg) 39.2 ± 9.1 39.0 ± 10.9 39.0 ± 9.2 40.2 ± 7.7 0.933
Postoperative data:
Postoperative use of piritramid (mg) 12.2 ± 7.7 10.5 ± 7.2 14.0 ± 7.8 8.2 ± 6.6 0.152
PACU time (min) 86.8 ± 48.5 79.1 ± 37.9 91.9 ± 57.9 82.0 ± 31.1 0.726
Brice questionnaire:
2 h post-anaesthesia (n) (awareness/dreams) 0/3 (0/6) 0/1 (0/9) 0/1 (0/4) 0/1 (0/9) 0.756
12 h post-anaesthesia (n) (awareness/dreams 0/1 (0/2) 0/0 (0/0) 0/1 (0/4) 0/0 (0/0) 0.649
Data are presented as mean±SD (normally distributed data) or as absolute numbers (with the percentage (%) of the whole group). PACU, post-anaesthesia
care unit.
Table 3 Comparison of ideal group that obtained same mode during wash-in and maintenance
Full-ECO mode Full-AUTO mode
p-value(n = 4) (n = 4)
Xenon wash-in phase:
Duration of Wash-in (min) 16.8 ± 1.0§§ 11.3 ± 1.3 0.000
Total xenon consumption (l) 7.8 ± 0.5§§ 9.6 ± 0.9 0.010
Maintenance of anaesthesia:
Time of maintenance (min) 128.5 ± 10.7 138.3 ± 9.2 0.217
Total xenon consumption (l) 12.0 ± 3.6§ 18.2 ± 3.1 0.041
Mean consumption (l/hour) 5.5 ± 1.4§ 7.8 ± 0.9 0.034
Mean FiO2 concentration (Vol%) 34.8 ± 0.8 33.1 ± 1.5 0.092
Mean Expiratory Xe concentr. (Vol%) 54.3 ± 1.4§§ 60 ± 1.3 0.001
Overall xenon consumption:
Xenon usage 1st hour (l/min) 0.181 ± 0.021§ 0.256 ± 0.025 0.018
Xenon usage 2nd hour (l/min) 0.115 ± 0.034 0.141 ± 0.012 0.198
Xenon usage 3rd hour (l/min) 0.078 ± 0.018 0.128 ± 0.025 0.290
Time of xenon application (min) 145 ± 10.5 149.5 ± 8.3 0.217
Mean xenon consumption (l/hour) 8.2 ± 1.3§§ 11.1 ± 0.5 0.041
Total xenon consumption (l) 19.8 ± 3.8§§ 27.8 ± 2.4 0.037
Data are presented as as mean±SD (normally distributed data). Bold italic P-values indicate significant difference between the groups (p < 0.05), §(§) = p < 0.05
(0.01) vs. Full-AUTO mode.
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Figure 3 Comparison of ideal groups. Full-ECO (n = 4) and Full-AUTO (n = 4) delivery mode by the means of xenon flow and end-expiratory
xenon concentration throughout xenon application. Data are presented as mean ± standard deviation. A and B corresponds to Full-AUTO mode.
C and D corresponds to Full-ECO mode.
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xenon was comparable between the groups, total xenon
consumption during maintenance showed a tendency of
being lowest in the ECO group (p = 0.172), becoming
significant when comparing the hourly xenon usage
(p = 0.049). Comparison of hourly xenon usage during
1st, 2nd and 3rd hour between the groups revealed a
lowest xenon usage in the ECO group that significantly
differed from MANUAL group (1st hour) and from
AUTO group (2nd and 3rd hour of maintenance)
(Table 4). Accordingly the overall xenon consumption
was lowest in the ECO group throughout xenon applica-
tion and showed a significant difference to the MAN-
UAL group. Likewise the mean expiratory xenon
concentration in the ECO group was significantly re-
duced in comparison to AUTO and MANUAL group
(55.9 ± 2.4vol% (ECO) vs. 59.7 ± 2.7vol% (AUTO) vs.
57.0 ± 2.5vol% (MANUAL)); p = 0.000). Interestingly data
for either mean xenon concentration, xenon usage
per hour or mean xenon consumption showed reduced
standard deviation compared to the AUTO orMANUAL group reflecting the well-standardized pro-
cedure of ECO mode (Table 4).
Learning curve
Figure 4 illustrates the learning curve that has been
recorded between February 2009 to November 2010 in
48 patients. The linear graphic represents the evolution of
xenon consumption and shows a visual tendency towards
reduction of gas consumption. Within two years we ob-
served a decrease in xenon consumption of −4.6 L in over-
all quantity per anaesthesia and of −3.9 L per hour.
Present learning curve has been constantly developed
by self-implication and self-dedication of the anaesthesi-
ology stuff with no particular training or specific refresh-
ing courses since the initial training provided in 2008.
Overall xenon consumption
The total xenon consumption in 48 patients was 1170 L
that nearly equals to the volume of one LENOXe B10
cylinder. The overall xenon consumption corresponds to
about 101 hours of anaesthesia (mean duration: 2 hours)
Table 4 Intraoperative data on xenon consumption during wash-in, maintenance and overall consumption
All ECO Mode AUTO Mode MANUAL Mode p-value
(n = 48) (n = 11) (n = 26 ) (n = 11 )
Xenon wash-in phase:
Duration of wash-in (min) 11.5 ± 2.7 13.7 ± 2.8 11.0 ± 1.7§ 10.2 ± 3.2§§ 0.002
Denitrogenation (min) 9.3 ± 4.3 8.1 ± 4.7 9.6 ± 3.4 9.9 ± 5.8 0.556
Total xenon consumption (l) 9.4 ± 2.1 8.6 ± 0.9 8.9 ± 0.9 11.1 ± 3.7*§§ 0.005
Maintenance of anaesthesia:
Time of maintenance (min) 115 ± 44 111 ± 30 113 ± 53 123 ± 30 0.781
Total xenon consumption (l) 15.0 ± 11.1 9.9 ± 3.6 15.7 ± 11.9 18.5 ± 12.8 0.172
Mean xenon usage (l/hour) 7.5 ± 3.6 5.2 ± 1.1 7.8 ± 2.6§ 8.9 ± 6.0§ 0.049
Mean FiO2 concentration (Vol%) 34.6 ± 2.6 34.9 ± 1.4 33.8 ± 2.6 36.2 ± 2.7* 0.029
Mean expiratory xenon concentration 58.2 ± 3.0 55.9 ± 2.4 59.7 ± 2.7§§ 57.0 ± 2.5* 0.000
Overall xenon consumption:
Time of anaesthesia (min) 142.8 ± 44.1 142.6 ± 32.4 135.0 ± 51.0 161.3 ± 32.4 0.258
Time of xenon application (min) 126 ± 44 125 ± 32 124 ± 53 133 ± 30 0.842
Xenon usage 1st hour (l/min) 0.268 ± 0.121 0.205 ± 0.030 0.263 ± 0.082 0.347 ± 0.202 § 0.020
Xenon usage 2nd hour (l/min) 0.128 ± 0.042 0.098 ± 0.030 0.143 ± 0.042§ 0.115 ± 0.035 0.007
Xenon usage 3rd hour (l/min) 0.098 ± 0.056 0.080 ± 0.043 0.112 ± 0.050§ 0.085 ± 0.077 0.042
Mean xenon consumption (l/hour) 11.9 ± 4.0 9.2 ± 1.9 12.5 ± 2.6 13.4 ± 6.7§ 0.031
Total xenon consumption (l) 24.4 ± 11.4 18.5 ± 3.7 24.7 ± 11.5 29.6 ± 14.3§ 0.033
Data are presented as mean ± SD (normally distributed data). Bold italic P-values indicate significant difference between the groups (p > 0.05), §(§) = p < 0.05(0.01)
vs. ECO, *(*) = p < 0.05(0.01) vs. AUTO.
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24 hours MANUAL Mode and 23 hours in ECO Mode.
Discussion
The results of the present study showed that for the same
depth and duration of anaesthesia xenon consumption can
effectively be reduced by using the xenon delivery mode
ECO of Felix Dual respirator during general surgery.
Today an increasing body of evidence indicates the nu-
merous favourable effects since the introduction of xenonFigure 4 Illustration of the learning process within the entire observain clinical practice in 1990 [18]. While high costs and re-
stricted availability still limit the introduction and general
use of xenon into clinical practice, various promising tech-
nical advances were investigated for an effective reduction
of xenon waste. [15, 19, 20]. In view of low patient uptake
of xenon (about 2.5-4l/h), closed-circuit respirators have
been developed and adapted in the past decade in order to
provide an economical xenon delivery [21].
Since 2007–2008 (depending on countries), the com-
mercially available closed-circuit respirator Felix Dualtion period (24 month) in all patients.
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xenon anaesthesia in the clinical practice. Today Felix
Dual is distinguished by a limited but real clinical use in
the daily practice as well as in completed or currently
running large multicentre studies investigating the effect
of xenon on outcome of patients [clinicaltrails.gov iden-
tifier: NCT00919126 (HERACLITE), NCT01199276
(HIPELD), NCT01120405 (CARVASAXe), NCT012941
63 (ON-PUMP CABG), NCT01167803 (OBESE PHRC),
NCT01262729 (Xenon-MTH-study), NCT01285271
(CARDIAX)]. Although increasing experimental and
clinical evidence promotes the use of balanced xenon
anaesthesia in various clinical settings, data about tech-
nical progress or xenon sparing effects of xenon respira-
tors are still sparse.
Felix Dual offers encouraging technical innovations -
more precisely an automated AUTO and ECO xenon
delivery mode aiming to reduce an excessive waste of
xenon. Therefore we investigated and compared the
present delivery modes with the not-automated MAN-
UAL mode in order to reveal any potentially sparing
strategies. Since use of the 3 delivery modes were not
standardized and left to the discretion of performing
anaesthesiologist, we classified the enrolled patients
according to their delivery mode during maintenance for
final analysis. However, we identified two groups of pa-
tients that received either full ECO or AUTO mode for
wash-in and maintenance and compared the major char-
acteristics. Herein the comparison of xenon during wash-
in and maintenance as well as the xenon usage per hour
indicated a significantly reduced xenon consumption in
the ECO application mode. In addition the mean
end-expiratory xenon concentration was significantly de-
creased in the Full-ECO group and together with xenon
flow did not show major changes (low standard deviation)
during the duration, indicating the robust delivery process.
Previous studies repeatedly demonstrated that con-
sumption and/or waste of xenon was remarkably ele-
vated within the wash-in period aiming to remove
accumulated nitrogen and accelerate time to target con-
centration of xenon [15, 22]. It`s important to note that
a significant and irreducible part of xenon used during
wash-in corresponds to the xenon volume needed to sat-
urate the fast compartment of the patient`s body (several
litres of xenon) as well as to saturate the respirator in-
ternal volume and tubes (estimated to 3l xenon). While
xenon anaesthesia needs to target approximately 60% ex-
piratory concentration with inspiratory O2 content not
lower than 30%, adequate denitrogenation of patients is
basically important to eliminate as much as possible ni-
trogen that is trapped in the body. However, time of pre-
oxygenation (before intubation) and denitrogenation
(after intubation) was comparable between the groups.
While use of high-flow is frequently necessary duringwash-in period, previous studies already supposed induc-
tion period to offer most potential to reduce waste of
xenon [15, 22].
Recent findings are in line with our findings and total
xenon consumption of all patients was apparently
highest during wash-in and 1st hour of xenon anaesthe-
sia, when compared to maintenance. Xenon usage sig-
nificantly decreased throughout further application.
Considering the xenon usage within the separated appli-
cation groups showed that xenon consumption within
the 1st hour was lowest in the ECO group. This mode
was specially designed to inject xenon at an appropriate
low flow that corresponds to xenon and O2 patient
uptake. Furthermore the ECO mode provided the lowest
xenon application during maintenance of anaesthesia
resulting in a most reduced total xenon consumption,
which is independent from duration of application. Ac-
cordingly, the patients in the ECO group exhibited lowest
overall xenon consumption throughout the entire xenon
application period, which significantly differed to the not-
standardized and not-automated MANUAL mode.
Interestingly we observed a significantly reduced ex-
piratory xenon concentration in ECO mode (in compari-
son to AUTO and MANUAL mode) that might further
indicate a xenon sparing effect. Despite these promising
sparing effects of ECO mode, the reduced xenon flow
might pose a serious challenge when fast adaption of ex-
piratory xenon concentration is needed to maintain an
adequate anaesthetic depth. However, the recorded BIS
values in al patients were within the recommended ref-
erence range and did not reveal any signs of major vari-
ation. Likewise postoperative evaluation of intraoperative
awareness by the means of Brice questionnaire were
negative [17].
In view of a significant reduced usage of xenon in the
ECO mode, which was most pronounced in the full
ECO group, this delivery mode may provide a promising
strategy for an effective costs reduction per anaesthesia.
Assuming a price of more or less 20 € for 1L xenon
(frequently announced on congresses for LENOXe an-
aesthesia licensed xenon, Air Liquide, France) we calcu-
lated a cost reduction from 592 € to 370 € when
compared to the not-automated MANUAL mode. Given
the presented learning curve, showing a constant decrease
of the overall and hourly xenon consumption, these find-
ings might as well indicate a promising approach for
effective cost reduction. Since this development based
alone on the experience of involved anaesthesiologists, it
remains speculative, if an additional training or periodic
refreshing courses would have further improved the per-
formance of the anaesthesiologists team.
Of note, while conducting this observational study,
further improvements have been integrated in Felix Dual
and a new software upgrade is available since 2011,
Stoppe et al. Medical Gas Research 2013, 3:12 Page 10 of 11
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ECO mode and to improve the precision of AUTO
mode. Therefore present results could even be rein-
forced by the new software version of Felix Dual. How-
ever, further studies would be needed to evaluate current
progress in xenon reduction.
We have to acknowledge that previous studies already
demonstrated less xenon consumption throughout in-
duction and maintenance of anaesthesia [15]. The rea-
sons for that might be due to the single use of xenon as
hypnotic agent without additional use of propofol. Like-
wise the target concentration of previous studies was
less than the chosen concentration in the present study.
The present results have to be viewed in the light of a
limited retrospective, observational study. Therefore we
acknowledge that allocation of patients into ECO,
AUTO and MANUAL groups was left to the discretion
of performing physician and was not randomized. Fur-
thermore sample size of patients might not be ad-
equately powered and therefore present results have to
be interpreted cautiously and viewed as only hypothesis
generating. However, the present findings indicate a
promising approach for an effective reduction of xenon
waste during general anaesthesia. Further studies in lar-
ger patient population are needed to investigate this
promising approach and encourage further technical de-
velopments that might render xenon`s further introduc-
tion into clinical use.
In conclusion, the closed-circuit respirator Felix dual
offers a promising approach to effectively control xenon
consumption in patients undergoing general surgery.
The delivery mode ECO showed lowest usage of xenon
that was independent from duration of xenon applica-
tion or applied mean xenon dosage. In comparison to
not-automated application by the means of MANUAL
mode, the use of ECO mode resulted in about 40% re-
duction of xenon consumption throughout entire xenon
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